London (PRWEB) December 02, 2013
Read more
Study Objectives
This study of the academic and pharma/biotech sectors in North America and Europe provides an analysis of the market for primary cells and an assessment of the brand equity for the leading companies who serve this market. This report also describes the emerging market for stem cell-derived differentiated.